Menu
At IKF, we understand the importance of advancing science-driven research. Founded by oncologists who have conducted their own trials, we know the unique needs and challenges faced by academic groups and innovative biotech companies.
What sets us apart is our collaborative research philosophy. Through different models of collaboration, we work hand-in-hand with our partners to create solutions for the development of new therapies and medicines that offer significant advantages over the classical pharma-CRO business model.
Our commitment to academic and science-driven biotech partners extends beyond financial considerations. We recognize the realities of limited budgets and milestone-dependent funding and therefore engage in risk-sharing approaches.
If you would like to learn more about our collaborative models and how IKF can support your research, please contact us.
Comprehensive Research Organization (CRO) at IKF
For collaborative clinical trials, IKF has established its own high-quality Comprehensive Research Organization (CRO). This ensures full sponsor responsibilities, strict regulatory compliance, and operational excellence throughout all phases of clinical research.
Our services include (but are not limited to):
Our data management focuses on quality control and data integrity of the clinical trial database – from database setup to database lock. We provide specification and development of user-friendly electronic case report forms (eCRFs) based on a well-structured database to ensure high-quality data for statistical analysis.
Statistical parameters play an important role in ensuring the overall success of a clinical trial. Therefore, our statistics team is involved in the planning of any clinical trial from the very beginning and accompanies it through all trial stages, closely cooperating with the data management.